Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sequenom's MaterniT21 Plus; Milford Medical Lab's Lyme Disease Test

Premium

The Mayo Medical Laboratories will now offer Sequenom's MaterniT21 Plus test to patients at high risk for fetal chromosome abnormalities. The test uses next-generation sequencing to noninvasively screen for fetal aneuploidies in chromosomes 21, 18, and 13, as well as the X and Y chromosomes. It also reports some subchromosomal microdeletions and microduplications.


Milford Medical Laboratory in Connecticut is now offering a Sanger sequencing-based test for Borrelia burgdorferi and Borrelia miyamotoi, which cause Lyme disease and Lyme disease-like infection. The test sequences a target segment of the bacterial16S ribosomal RNA gene and is available for $150.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.